Announcement

Collapse
No announcement yet.

Rituximab Performance to include in SPMS patients

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    Rituximab Performance to include in SPMS patients

    An immune system drug may help prevent or slow complications in a type of multiple sclerosis known as secondary progressive MS, a new study finds.
    The medication is called rituximab (Rituxan). It's used to treat a number of conditions, including certain blood cell cancers and the autoimmune condition rheumatoid arthritis.
    The new Swiss study found that MS patients taking the drug reported less disabling symptoms over a 10-year period than those who didn't. People taking rituximab also had a slower progression of MS symptoms.

    https://www.mdmag.com/medical-news/r...iple-sclerosis
Working...
X